Anne E.G. Lenferink

2.5k citations

43 papers · 2.0k indexed · h-index 18

Molecular Biology top 5%
Oncology top 2%
Radiology, Nuclear Medicine and Imaging top 5%
Genetics top 10%
Cancer Research top 10%

Co-authors: Carlos L. Arteaga Maureen D. O'Connor‐McCourt Jean F. Simpson James T. Forbes Mark X. Sliwkowski Paul I. Pisacane Hirokazu Kurokawa F. Michael Yakes
Topics: Monoclonal and Polyclonal Antibodies Research (15 papers)HER2/EGFR in Cancer Research (11 papers)Glycosylation and Glycoproteins Research (10 papers)
Cited by: Oncology Molecular Biology Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Communications
Partner nations: Canada United States Netherlands

In The Last Decade

Anne E.G. Lenferink

43 papers receiving 1.9k citations

Peers

Countries citing papers authored by Anne E.G. Lenferink

Since Specialization

Citations

This map shows the geographic impact of Anne E.G. Lenferink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne E.G. Lenferink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne E.G. Lenferink more than expected).

Fields of papers citing papers by Anne E.G. Lenferink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne E.G. Lenferink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne E.G. Lenferink. The network helps show where Anne E.G. Lenferink may publish in the future.

Co-authorship network of co-authors of Anne E.G. Lenferink

This figure shows the co-authorship network connecting the top 25 collaborators of Anne E.G. Lenferink. A scholar is included among the top collaborators of Anne E.G. Lenferink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne E.G. Lenferink. Anne E.G. Lenferink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern 2023 ·Frontiers in Immunology ·Tyler M. Renner,Bassel Akache,Matthew Stuible,Nazanin Rohani,(unknown),Lise Deschatelets,Renu Dudani,Blair A. Harrison,Jason Baardsnes,(unknown),Jennifer J. Hill,Usha D. Hemraz,Sophie Régnier,Anne E.G. Lenferink,Yves Durocher,Michael J. McCluskie	6
2	Affinity-controlled capture and release of engineered monoclonal antibodies by macroporous dextran hydrogels using coiled-coil interactions 2023 ·mAbs ·(unknown),(unknown),(unknown),(unknown),Anne E.G. Lenferink,Elena Pazos,Nick Virgilio,Xavier Banquy,Grégory De Crescenzo,Yves Durocher	5
3	Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern 2022 ·npj Vaccines ·Bassel Akache,Tyler M. Renner,Matthew Stuible,Nazanin Rohani,(unknown),Lise Deschatelets,Renu Dudani,Blair A. Harrison,Christian Gervais,Jennifer J. Hill,Usha D. Hemraz,Edmond Lam,Sophie Régnier,Anne E.G. Lenferink,Yves Durocher,Michael J. McCluskie	15
4	Impact of IgG1 N-glycosylation on their interaction with Fc gamma receptors 2020 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Denis Brochu,Michel Gilbert,(unknown),(unknown),Anne E.G. Lenferink,(unknown),Olivier Henry,Grégory De Crescenzo,Yves Durocher	15
5	Engineering and Therapeutic Application of Single-Chain Bivalent TGF-β Family Traps 2012 ·Molecular Cancer Therapeutics ·John C. Zwaagstra,Traian Sulea,Jason Baardsnes,Anne E.G. Lenferink,Cathy Collins,(unknown),(unknown),Suzanne Grothé,Sazzad M. Hossain,(unknown),Denis L’Abbé,(unknown),Brian Cass,Yves Durocher,Maureen D. O'Connor‐McCourt	17
6	Molecular imaging of breast tumors using a near‐infrared fluorescently labeled clusterin binding peptide 2011 ·International Journal of Cancer ·(unknown),(unknown),(unknown),(unknown),Dmitri Tolkatchev,(unknown),Ping Xu,Feng Ni,Maureen D. O'Connor‐McCourt,Anne E.G. Lenferink	10
7	Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies 2009 ·Oncogene ·Anne E.G. Lenferink,(unknown),André Nantel,E. Wang,Yves Durocher,M. Banville,(unknown),Anne Marcil,Mark R. Wilson,Maureen D. O'Connor‐McCourt	74
8	Escherichia coli expression and refolding of E/K-coil-tagged EGF generates fully bioactive EGF for diverse applications 2008 ·Protein Expression and Purification ·Phuong Uyen Le,Anne E.G. Lenferink,Maxime Pinard,Jason Baardsnes,Bernard Massie,Maureen D. O'Connor‐McCourt	16
9	Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-β and Neu pathway signaling studies: identification of a novel model for TGF-β-induced epithelial-to-mesenchymal transition 2004 ·Breast Cancer Research ·Anne E.G. Lenferink,(unknown),(unknown),Maureen D. O'Connor‐McCourt	15
10	Expression of TGF‐β type II receptor antisense RNA impairs TGF‐β signaling in vitro and promotes mammary gland differentiation in vivo 2003 ·International Journal of Cancer ·Anne E.G. Lenferink,(unknown),(unknown),Alain Guimond,Maureen D. O'Connor‐McCourt	15
11	ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. 2001 ·PubMed ·Anne E.G. Lenferink,Dagmar Busse,W. Michael Flanagan,F. Michael Yakes,Carlos L. Arteaga	156
12	Cyclin-Dependent Kinase Inhibitor P27Kip1 Is Required for Mouse Mammary Gland Morphogenesis and Function 2001 ·The Journal of Cell Biology ·Rebecca S. Muraoka,Anne E.G. Lenferink,Jean F. Simpson,Dana M. Brantley,(unknown),F. Michael Yakes,Carlos L. Arteaga	67
13	Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. 2000 ·PubMed ·Hirokazu Kurokawa,Anne E.G. Lenferink,Jean F. Simpson,Paul I. Pisacane,Mark X. Sliwkowski,James T. Forbes,Carlos L. Arteaga	310
14	Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-α bigenic mice 2000 ·Proceedings of the National Academy of Sciences ·Anne E.G. Lenferink,Jean F. Simpson,Laura K. Shawver,Robert J. Coffey,James T. Forbes,Carlos L. Arteaga	112
15	The EGF domain: Requirements for binding to receptors of the ErbB family 2000 ·Vitamins and hormones ·E.J.J. van Zoelen,Catelijne Stortelers,Anne E.G. Lenferink,(unknown)	37
16	The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin 1998 ·Oncogene ·Ronit Pinkas‐Kramarski,Anne E.G. Lenferink,Sarah Bacus,Ljuba Lyass,(unknown),Leah N. Klapper,Eldad Tzahar,Michael Sela,(unknown),Yosef Yarden	75
17	Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers 1998 ·The EMBO Journal ·Anne E.G. Lenferink	322
18	Identification of the Minimal Requirements for Binding to the Human Epidermal Growth Factor (EGF) Receptor Using Chimeras of Human EGF and an EGF Repeat of Drosophila Notch 1998 ·Journal of Biological Chemistry ·(unknown),(unknown),Anne E.G. Lenferink,E.J.J. van Zoelen	15
19	Rational Design for the Development of Epidermal Growth Factor Receptor Antagonists 1996 ·Pathology - Research and Practice ·E.J.J. van Zoelen,Anne E.G. Lenferink,(unknown),(unknown)	8
20	A Single Amino Acid Exchange, Arg-45 to Ala, Generates an Epidermal Growth Factor (EGF) Mutant with High Affinity for the Chicken EGF Receptor 1995 ·Journal of Biological Chemistry ·(unknown),Anne E.G. Lenferink,(unknown),Jacqueline J.L. Jacobs,(unknown),(unknown),E.J.J. van Zoelen	23

About Anne E.G. Lenferink

Anne E.G. Lenferink is a scholar working on Immunology and Allergy, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 43 papers that have together received 2.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (11 papers) and Glycosylation and Glycoproteins Research (10 papers). The work is most often cited by research in Oncology (1.1k citations), Molecular Biology (1.3k citations) and Cancer Research (280 citations). Anne E.G. Lenferink has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Carlos L. Arteaga, Maureen D. O'Connor‐McCourt, Jean F. Simpson, James T. Forbes, Mark X. Sliwkowski, Paul I. Pisacane, Hirokazu Kurokawa, F. Michael Yakes, E. Wang and Edwin Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact